Network Meta-analysis of Seven Glucagon-Like Peptide-1 Receptor Agonists: A Focus on Cardiovascular Outcome Trials Data

被引：1
|
作者：
Alfayez, Osamah
Alkhezi, Omar
Almutairi, Abdulaali R.
机构：
来源：
DIABETES | 2020年 / 69卷
关键词：
D O I：
10.2337/db20-445-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
445-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Glucagon-Like Peptide-1 Receptor Agonists in the Management of Obesity: An Economics Meta-Analysis
    Bloomfield, Grace C.
    Chen, Yuan
    Cunningham, Marcus H.
    Bartoletti, Sebastiano
    Azagury, Dan E.
    Alimi, Yewande R.
    Prindeze, Nicholas
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2024, 239 (05) : S25 - S25
  • [22] Effects of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight: A Meta-Analysis
    Monami, Matteo
    Dicembrini, Ilaria
    Omarchionni, Niccolo
    Rotella, Carlo M.
    Mannucci, Edoardo
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [23] Glucose Lowering Efficacy of Glucagon-Like Peptide-1 Receptor Agonists: A Meta-Analysis
    Vilsboll, Tina
    Christensen, Mikkel
    Knop, Filip K.
    Gluud, Lise L.
    DIABETES, 2011, 60 : A295 - A295
  • [24] Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials
    Monami, Matteo
    Marchionni, Niccolo
    Mannucci, Edoardo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2009, 160 (06) : 909 - 917
  • [25] Effect of glucagon-like peptide-1 receptor agonists on renal function: A meta-analysis of randomized controlled trials
    Simental-Mendia, Mario
    Linden-Torres, Enrique
    Sanchez-Garcia, Adriana
    Sahebkar, Amirhossein
    Simental-Mendia, Luis E.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (08) : 3566 - 3576
  • [26] Impact of glucagon-like peptide-1 receptor agonists on adiponectin concentrations: A meta-analysis of randomized controlled trials
    Simental-Mendia, Luis E.
    Sanchez-Garcia, Adriana
    Linden-Torres, Enrique
    Simental-Mendia, Mario
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 87 (11) : 4140 - 4149
  • [27] Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials
    Mabilleau, Guillaume
    Mieczkowska, Aleksandra
    Chappard, Daniel
    JOURNAL OF DIABETES, 2014, 6 (03) : 260 - 266
  • [28] Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis
    Bethel, M. Angelyn
    Patel, Rishi A.
    Merrill, Peter
    Lokhnygina, Yuliya
    Buse, John B.
    Mentz, Robert J.
    Pagidipati, Neha J.
    Chan, Juliana C.
    Gustavson, Stephanie M.
    Iqbal, Nayyar
    Maggioni, Aldo P.
    Ohman, Peter
    Poulter, Neil R.
    Ramachandran, Ambady
    Zinman, Bernard
    Hernandez, Adrian F.
    Holman, Rury R.
    LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (02): : 105 - 113
  • [29] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [30] Effects of glucagon-like peptide-1 receptor agonists on cardiovascular and renal outcomes: A meta-analysis and meta-regression analysis
    Yoshiji, Satoshi
    Minamino, Hiroto
    Tanaka, Daisuke
    Yamane, Shunsuke
    Harada, Norio
    Inagaki, Nobuya
    DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1029 - 1037
12345